<DOC>
	<DOC>NCT00193687</DOC>
	<brief_summary>Study of the long-term efficacy and safety of bifeprunox in the treatment of schizophrenia. Extension to study S154.3.001.</brief_summary>
	<brief_title>Bifeprunox in the Treatment of Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>diagnosis of schizophrenia, understand nature of study, able to be managed in outpatient setting for longterm bifeprunox treatment current primary diagnosis other than schizophrenia, suicide risk, diagnosis or history of substance abuse, uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>open-label study in the treatment of schizophrenia</keyword>
</DOC>